West Announces First-Quarter Dividend
Rhea-AI Summary
West Pharmaceutical Services (NYSE: WST) has declared its first-quarter 2025 dividend. The Board of Directors approved a dividend payment of $0.21 per share, which will be distributed on February 11, 2025. Shareholders who are on record as of February 7, 2025, will be eligible to receive this dividend payment.
Positive
- Maintains consistent dividend payment, demonstrating financial stability
- Continues to return value to shareholders through regular dividend distributions
Negative
- None.
News Market Reaction
On the day this news was published, WST declined 0.52%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 43 billion components and devices each year.
Headquartered in
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
View original content to download multimedia:https://www.prnewswire.com/news-releases/west-announces-first-quarter-dividend-302362284.html
SOURCE West Pharmaceutical Services, Inc.